BioLineRx (BLRX) Return on Equity (2015)
BioLineRx (BLRX) posted Return on Equity of 0.0% for Q1 2015.
BioLineRx (BLRX) has 1 years of Return on Equity data on file, last reported at 0.0% in Q1 2015.
- In Q1 2015, Return on Equity changed N/A year-over-year to 0.0%; the TTM figure through Mar 2015 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
- Return on Equity steadied at 0.0% in Q1 2015.
- Across five years, Return on Equity topped out at 0.0% in Q1 2015 and bottomed at 0.0% in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -0.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.01% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 0.00% |